It is notable that CRP ≥2 mg/L was highly prevalent in all of the chronic diseases studied, ranging from 39.6% of people with cancer to 85.6% of people with class 3 obesity, and was more prevalent in people with greater multimorbidity (Figure 1). Here, CRP is linked to obesity disorder.